Gene therapy for hemophilia delayed until 2022 after FDA rejects one-time treatment, shocking doctors and scientists
“Jon Entine was truly an incredible and captivating speaker. A must see and hear phenomenon.”— Diane Scar, Jewish National Fund
Reach out to explore availability!